Trials / Completed
CompletedNCT02254837
Zilver PTX Post-Market Study in Japan
Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 909 (actual)
- Sponsor
- Cook Group Incorporated · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Japanese post market clinical study of the Zilver PTX device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Zilver PTX Drug-Eluting Stent |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2018-06-30
- Completion
- 2018-06-30
- First posted
- 2014-10-02
- Last updated
- 2019-07-12
Source: ClinicalTrials.gov record NCT02254837. Inclusion in this directory is not an endorsement.